HeartFlow raises a $36 million equity financing round for its system for non-invasive measurement of fractional flow reserve.
HeartFlow said it raised more than $35.8 million, 2 months after gaining FDA clearance for its non-invasive fractional flow reserve test to diagnose and treat coronary artery disease.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1KTfs5N
Cap comentari:
Publica un comentari a l'entrada